Variant report

Variant	nsv970088
Chromosome Location	chr6:26814715-26844272
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 288 )
Associated
traits (count: 103 )

Variant overlapped rSNPs/rCNVs (count:288 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs183582170	chr6:26826408-26826409	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs187696982	chr6:26826422-26826423	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs142085168	chr6:26826462-26826463	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs543129996	chr6:26826486-26826487	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs193248549	chr6:26826504-26826505	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs535079410	chr6:26826505-26826506	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs114128168	chr6:26826555-26826556	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs143065886	chr6:26826557-26826558	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs537496231	chr6:26826694-26826695	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs556170450	chr6:26826714-26826715	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs576634142	chr6:26826729-26826730	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs576316652	chr6:26826792-26826793	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs113032355	chr6:26826804-26826805	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	mRNA abundance
14	rs185707524	chr6:26826870-26826871	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs373165336	chr6:26826902-26826903	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs571916663	chr6:26826911-26826912	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs540676494	chr6:26826964-26826965	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs2984034	chr6:26827002-26827003	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs2984035	chr6:26827007-26827008	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs563883039	chr6:26827022-26827023	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs532756732	chr6:26827045-26827046	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs190069813	chr6:26827084-26827085	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs559591056	chr6:26827115-26827116	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs529989050	chr6:26827128-26827129	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs529563332	chr6:26827145-26827146	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs549422815	chr6:26827148-26827149	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs566230622	chr6:26827168-26827169	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs181601796	chr6:26827242-26827243	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs551896858	chr6:26827333-26827334	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs571806268	chr6:26827407-26827408	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs537029990	chr6:26827502-26827503	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs375877005	chr6:26827534-26827535	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs557298959	chr6:26827571-26827572	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs184050023	chr6:26827577-26827578	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs535697297	chr6:26827589-26827590	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs377227880	chr6:26827650-26827651	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs571904549	chr6:26827703-26827704	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs2475058	chr6:26827772-26827773	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs188737562	chr6:26827775-26827776	Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs557414709	chr6:26827815-26827816	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs181381835	chr6:26827824-26827825	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs2475063	chr6:26827833-26827834	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs2475067	chr6:26827847-26827848	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs111722403	chr6:26827850-26827851	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs2475068	chr6:26827896-26827897	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
46	rs369978722	chr6:26827928-26827929	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs2475070	chr6:26827985-26827986	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs547677189	chr6:26834603-26834604	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs2475135	chr6:26834606-26834607	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs190913449	chr6:26834642-26834643	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:103)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	16790693	CNVD
Breast cancer	22032731	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
T-cell lymphomas	19863542	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
small cell lung cancer	20016488	CNVD
Williams-beuren syndrome	16971481	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	21569311	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21364760	CNVD
early-passage human iPS cells	21368824	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD

Chromatin state (count:11 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:26826400-26826800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
2	chr6:26826600-26827200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
3	chr6:26826800-26827200	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
4	chr6:26827200-26828000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
5	chr6:26834600-26848800	Weak transcription	Liver	Liver
6	chr6:26838000-26866200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
7	chr6:26838400-26853400	Weak transcription	Adipose Nuclei	Adipose
8	chr6:26838800-26857600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
9	chr6:26839000-26850600	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
10	chr6:26841400-26866200	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
11	chr6:26843600-26848600	Weak transcription	Fetal Stomach	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links